New Alzheimer vaccine to be tested in Europe
A new vaccine against Alzheimer’s, developed by the Austrian biotechnology firm Affiris, will soon be tested in six European countries, the company announced Friday.
Visit link:
New Alzheimer vaccine to be tested in Europe
Related posts:
- Alzheimers Vaccine Closer To Reality
- “Vaccine-Like” Drug Tested In Alzheimer’s Patients
- Alzheimer’s Disease Drug Developed at Roskamp Institute Approved for Key Clinical Trial Funding in Europe
- Alzheimer’s Disease Drug Developed At Roskamp Institute Approved For Key Clinical Trial Funding In Europe
- Alzheimer’s disease: Tested